Skip to main content
. 2013 Jul 25;3(3):435–448. doi: 10.3390/biom3030435

Figure 2.

Figure 2

Altered cerebroside levels in patient specimens with pancreatic cancer. LC-MS/MS was utilized to quantify cerebrosides from patient specimens. Cerobrosides with a d18:1 backbone with fatty acids from 14 to 26 carbons were assessed. Molecular species of cerebrosides were quantified from pancreas tissues (A); and corresponding plasma samples (B) from patients with pancreatitis, non-metastatic (nodal negative) pancreatic cancer, or metastatic (nodal positive) pancreatic cancer. * p < 0.05 assessed by t-test analysis.